| 摘要 |
A therapeutic composition for oral and parenteral administration in the treatment of oedemae in humans and animals comprises not less than 0.2% by weight of 4-chlorobenzene-1,3-disulphonamide and a compatible solid or a parenteral pharmaceutical carrier, said parenteral carrier comprising water and a solubilizer which is a non-toxic water-soluble hydroxyamine or a liquid containing a suspending agent. The solid form may be a tablet, powder or gelatin capsule using carriers such as starch lactose or talc. Suspending agents used are ethylene glycol, proteins, polysaccharides or lecithin. Solubilizers specified are glycosamine, N-methyl glycosamine, diethanolamine or diethylaminoethanol.
|
